Dementia Drugs Market
Dementia Drugs Market Scope: Industry Analysis, Market Size, Growth, Trends till 2030
Dementia Drugs Market Size and Growth
The global dementia drugs market was valued at USD 15.2 billion in 2023, and it is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.1% from 2023 to 2030, reaching USD 26.3 billion by 2030.
Companies Covered : (Covid-19 Impact Covered)
o Eisai Co., Ltd
o Biogen Inc
o Novartis AG
o Pfizer Inc
The dementia drugs market is poised for significant growth, driven by the increasing prevalence of dementia-related diseases, ongoing advancements in drug development, and a rising elderly population. While current treatments focus primarily on managing symptoms and slowing disease progression, emerging therapies such as monoclonal antibodies and neuroprotective drugs offer hope for more effective treatments in the future. As research efforts continue and new drugs enter the market, the dementia drugs sector is expected to expand further, providing better options for patients and caregivers alike.
Dementia Drugs Market Segmentation
By Application
• Alzheimer’s Disease
• Vascular Dementia
• Lewy Body Dementia
• Frontotemporal Dementia
By Product
• Cholinesterase Inhibitors
• NMDA Receptor Antagonists
• Combination Drugs
• Monoclonal Antibodies
Dementia Drugs Market Growth 2024-2030
Market Size (USD) $ X Billion USD
